Strategies for the treatment of hormone receptor-positive HER2-low breast cancer based on clinical practice: a round table discussion
{{output}}
Human epidermal growth factor receptor 2 (HER2)-low breast cancer is a newly identified targetable subset of breast tumors, and its clinical characteristics and treatment strategies are controversial. The emergence of novel anti-HER2 antibody-drug conjugate (A... ...
